---
title: "Hinge Health Earns Buy Rating on Robust Double-Digit Growth and Expanding Commercial Footprint"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294881065.md"
description: "William Blair analyst Ryan Daniels maintained a Buy rating on Hinge Health (HNGE), citing robust double-digit revenue and operating income growth, consistent earnings beats, and raised guidance. Strategic upsides include expanding commercial footprint, higher win rates with large employers, SMB penetration, and the Cylinder Health acquisition for GI care. Evercore ISI also maintained a Buy rating with a $100 price target."
datetime: "2026-08-04T22:35:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294881065.md)
  - [en](https://longbridge.com/en/news/294881065.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294881065.md)
---

# Hinge Health Earns Buy Rating on Robust Double-Digit Growth and Expanding Commercial Footprint

William Blair analyst Ryan Daniels has maintained their bullish stance on HNGE stock, giving a Buy rating today.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

Ryan Daniels has given his Buy rating due to a combination of factors, starting with Hinge Health’s consistently strong financial performance. The company is growing revenue and operating income at robust double‑digit rates, repeatedly beating Street expectations and raising its medium‑term guidance, which signals confidence in both demand and execution.

Moreover, Daniels sees strategic upside from Hinge Health’s expanding commercial footprint and product set. Rising win rates with large employers, successful penetration of the small and midsize business segment, and the acquisition of Cylinder Health to enter the sizable GI care market all support a sustained growth trajectory and reinforce his favorable view on the stock.

In another report released today, Evercore ISI also maintained a Buy rating on the stock with a $100.00 price target.

### Related Stocks

- [HNGE.US](https://longbridge.com/en/quote/HNGE.US.md)

## Related News & Research

- [Hinge Health to acquire Cylinder Health, expanding into gastrointestinal care | HNGE Stock News](https://longbridge.com/en/news/294863775.md)
- [Hinge Health agrees to buy HCC-backed Cylinder Health for $105 million cash](https://longbridge.com/en/news/295094515.md)
- [Bausch Health Announces 2026 Gastrointestinal Health Scholars Program Winners | BHC Stock News](https://longbridge.com/en/news/296102688.md)
- [12:11 ETCurative and Vytalize Health Finalize Network Agreement, Expanding Hassle-Free, $0-Copay Healthcare Access in the Northeast](https://longbridge.com/en/news/296129353.md)
- [Valion Bio Announces U.S. Government-Funded Entolimod Studies Targeting Lethal Radiation-Induced GI Injury | VBIO Stock News](https://longbridge.com/en/news/295673219.md)